NCT06671093View on ClinicalTrials.gov

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

June 28, 2028

Study Completion Date

October 30, 2028

Conditions
Chronic Hep BChronic Hepatitis bChronic HepatitisHBV
Interventions
GENETIC

Tune-401

Epigenetic gene silencing therapy

Trial Locations (3)

1010

RECRUITING

New Zealand Clinical Research, Auckland

Unknown

RECRUITING

Queen Mary Hospital, University of Hong Kong, Hong Kong

MD2025

RECRUITING

"PMSI Republican Clinical Hospital Timofei Mosneaga, Arensia Exploratory Medicine Phase I Unit", Chisinau

All Listed Sponsors
lead

Tune Therapeutics, Inc.

INDUSTRY